Aarthi Parvathaneni
Fred Hutch Cancer Center, The University of Texas Health Science Center
Papers
2
Total Citations
48
H-Index
2
About
Dr. Aarthi Parvathaneni is a leading head and neck surgical oncologist whose work focuses on refining surgical and post-operative strategies for oropharyngeal cancers, particularly in the context of transoral robotic surgery (TORS). Her research addresses critical challenges in treating unknown primary head and neck cancers and HPV-related (p16 positive) oropharyngeal squamous cell carcinoma (OPSCC). Her most cited work, a 2017 study on post-operative therapy following TORS for unknown primary cancers (41 citations), provides essential guidance for managing this diagnostically complex patient population. More recently, her 2023 study on clarifying margin status through multidisciplinary tumor board review after TORS for p16 positive OPSCC tackles a significant clinical dilemma—the frequent discrepancy between pathological margin reports and the true oncologic margin as determined by a team of experts. This work has direct implications for reducing unnecessary adjuvant therapy and improving patient outcomes. Dr. Parvathaneni’s contributions are shaping evidence-based protocols for minimally invasive surgery in head and neck oncology, making her a key voice in the evolving landscape of organ-preserving cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2